<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4EA2F8C3-F57F-4CCB-99F0-7FA2C4054E11"><gtr:id>4EA2F8C3-F57F-4CCB-99F0-7FA2C4054E11</gtr:id><gtr:name>Thai Institute of Science and Technological Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CBBDE17F-AE17-4C90-9CA6-DAF6835B3E48"><gtr:id>CBBDE17F-AE17-4C90-9CA6-DAF6835B3E48</gtr:id><gtr:name>Procter &amp; Gamble</gtr:name><gtr:address><gtr:line1>1 Procter and Gamble Plaza</gtr:line1><gtr:line4>Cincinnati</gtr:line4><gtr:line5>OH 45202</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0B3A89D7-53CF-4678-84A3-DB707E1B4A6B"><gtr:id>0B3A89D7-53CF-4678-84A3-DB707E1B4A6B</gtr:id><gtr:name>The Institute for In Vitro Sciences</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:department>Institute of Life Science Medical School</gtr:department><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4EA2F8C3-F57F-4CCB-99F0-7FA2C4054E11"><gtr:id>4EA2F8C3-F57F-4CCB-99F0-7FA2C4054E11</gtr:id><gtr:name>Thai Institute of Science and Technological Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CBBDE17F-AE17-4C90-9CA6-DAF6835B3E48"><gtr:id>CBBDE17F-AE17-4C90-9CA6-DAF6835B3E48</gtr:id><gtr:name>Procter &amp; Gamble</gtr:name><gtr:address><gtr:line1>1 Procter and Gamble Plaza</gtr:line1><gtr:line4>Cincinnati</gtr:line4><gtr:line5>OH 45202</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0B3A89D7-53CF-4678-84A3-DB707E1B4A6B"><gtr:id>0B3A89D7-53CF-4678-84A3-DB707E1B4A6B</gtr:id><gtr:name>The Institute for In Vitro Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4D194CC0-BCFA-494B-8AE8-F1120FC7A5A1"><gtr:id>4D194CC0-BCFA-494B-8AE8-F1120FC7A5A1</gtr:id><gtr:firstName>Gareth</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Jenkins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000821"><gtr:id>52F9669F-F26D-423C-8925-086E8399A82A</gtr:id><gtr:title>Development of 3D human tissue models for toxicological (DNA damage) testing.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1000821</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Much of the highly regarded work carried out in the DNA damage group at Swansea is based on the use of human cell models of differing tissue origin and possessing specific genetic modifications (e.g. related to metabolic activation, DNA repair). These models are robust tools for studying the mechanisms of DNA damage induction and the consequences of such DNA damage. However, it is becoming clear that more complex models mimicking human exposure scenarios are needed. Bearing in mind the moves to reduce the use of animals in human safety testing, the use of 3D human tissue models is gaining much attention. This is particularly true for the cosmetics industry where a worldwide marketing ban, introduced in 2009 through a European Directive has made it impossible to test cosmetic ingredients in animals. 

Hence this application would allow the group at Swansea to gain significant knowledge from our partners at Unilever about the strengths and weaknesses of the various 3D tissue models. This would allow the development of in house models for toxicology testing through close partnering with experienced scientists at Unilever. Our colleagues at Unilever have a longstanding interest in developing 3D models (particularly skin) for cosmetics testing. We aim in this fellowship application to transfer that knowledge and skill base to Swansea, learn from external experts in the field about the latest developments in 3D models (skin initially) and carry out a proof of concept study to develop and use skin models to test DNA damage induction. We can then use our own significant experience in cellular DNA damage induction to compare the different cellular and tissue models to validate the tissue models for DNA damage detection.

We plan to develop a chromosome damage test (the micronucleus (MN) assay) for detecting DNA damage in intact 3D tissues. We will use commercially available 3D models (Epiderm) and also develop our own novel models. We have many years of experience with the MN assay in vitro, but in the case of the 3D models, the assay will require some modifications. Hence a secondary challenge (as well as developing suitable 3D models), is to validate the DNA damage detection in these tissues. We aim to use a recently purchased InCell Analyzer (GE Healthcare) to scan through the tissue sections (in Z-stacking mode) seeking out chromosomal fragments. After establishing the 3D models in Swansea, we will assess the ability of those models to detect DNA damage induced by 2-3 classic genotoxic agents. This will be a validation process and comparisons between this data and the cell model data already obtained by ourselves will provide interesting data on relative sensitivity of the systems. The validated models will then be available for scientists at both Swansea and SEAC to utilise.

The unique selling point of this application is the fact that this proposal builds on the close interactions between Swansea University and Unilever in the field of DNA damage that have been built up over the preceding years. Hence, there is a very strong collaboration already in existence which will increase the chances of success here enormously. This close interaction ensures that the goal of this proposal is shared by both partners providing the impetus necessary to drive the project forward to completion.</gtr:technicalSummary><gtr:fund><gtr:end>2012-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-11-09</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>68209</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Procter &amp; Gamble</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>3D model training (Curran laboratory)</gtr:description><gtr:id>FCD4AC50-4A5C-46AE-AB80-1E06F0365C27</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>R2S7eyCSE2S-2</gtr:outcomeId><gtr:partnerContribution>Rodger Curran's Institute has trained a PhD student from Swansea in state of the art epiderma (skin) models for DNA damage detection. This activity has been successfully transfered back to Swansea.</gtr:partnerContribution><gtr:piContribution>This project (Research leader fellowship to develop 3D tissue models) has led to a PhD student from Swansea visiting a leading US centre for tissue models to learn the skin (epiderm) system in order to carry out work here at Swansea.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Unilever</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Unilever Research and Development Vlaardingen B.V.</gtr:department><gtr:description>Unilever links</gtr:description><gtr:id>8181EA96-6DDF-4343-A982-31BD851F319F</gtr:id><gtr:impact>only just started in this phase, previous outputs through MRC initiative listed</gtr:impact><gtr:outcomeId>54492b1de25f82.00428351-1</gtr:outcomeId><gtr:partnerContribution>We have made further links with Unilever and have received &amp;pound;60,000 to fund a new PhD student. Scientitsts at Unilever will aid in our development of &amp;quot;passive dosing&amp;quot;. THis in kind contribution will be extremely valuable.
This link builds directly on from the MRC fellowship I recieved in which we developed close links to Unilver whilst developing 3D skin models for DNA damage analysis</gtr:partnerContribution><gtr:piContribution>We have made further links with Unilever and have received &amp;pound;60,000 to fund a new PhD student. Scientitsts at Unilever will aid in our development of &amp;quot;passive dosing&amp;quot;. THis in kind contribution will be extremely valuable.
This link builds directly on from the MRC fellowship I recieved in which we developed close links to Unilver whilst developing 3D skin models for DNA damage analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Thai Institute of Science and Technological Research</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:description>Thai Institute for Science and Technology</gtr:description><gtr:id>42418A55-A2C8-4E1F-A961-1871455A258D</gtr:id><gtr:impact>No outputs yet</gtr:impact><gtr:outcomeId>58b94fb07a6fb1.92193946-1</gtr:outcomeId><gtr:partnerContribution>TISTR invited myself, Professor Doak and Dr Chapman to attend an &amp;quot;animal alternatives&amp;quot; conference in Bangkok in September 2016. As well as presenting at this conference, visits to collaborating institutions in Bangkok were organised. Our Thai partners funded these visits.</gtr:partnerContribution><gtr:piContribution>An MOU now signed with TISTR to facilitate exchange visits of Thai scientists to Swansea to learn 3D skin DNA damage analysis and in vitro approaches to identify carcinogens</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Institute for In Vitro Sciences</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>3D model training (Curran laboratory)</gtr:description><gtr:id>580D8ECF-26D3-4584-A1BE-242B5521A9CD</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>R2S7eyCSE2S-1</gtr:outcomeId><gtr:partnerContribution>Rodger Curran's Institute has trained a PhD student from Swansea in state of the art epiderma (skin) models for DNA damage detection. This activity has been successfully transfered back to Swansea.</gtr:partnerContribution><gtr:piContribution>This project (Research leader fellowship to develop 3D tissue models) has led to a PhD student from Swansea visiting a leading US centre for tissue models to learn the skin (epiderm) system in order to carry out work here at Swansea.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Animal alternatives schools days</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FD6710BF-59C4-4317-A773-A777460879CF</gtr:id><gtr:impact>Organised 2 local school visits to my lab to showcase how animal alternative (in vitro) approaches can reduced animals used in scientific research.
The outreach events were funded by the NC3Rs</gtr:impact><gtr:outcomeId>58b95415c43a61.96285657</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LUSH prize</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Lush</gtr:fundingOrg><gtr:id>E42D5B2D-BF09-4F21-BDDD-C7BFB432251E</gtr:id><gtr:outcomeId>58b9501d703fe8.05872561</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>83000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC - CASE award</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>E143A401-326C-4875-8211-F67A82F2B57F</gtr:id><gtr:outcomeId>iY4z793Q49k</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>460000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs strategic award November 2011</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>NC/K500033/1</gtr:fundingRef><gtr:id>37B7B5AA-F283-4D18-9B8A-2E9E68DD7E26</gtr:id><gtr:outcomeId>az54oyoZUi90</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Industrial research funding scheme</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Unilever</gtr:fundingOrg><gtr:id>47ED3AA6-2B53-4826-B02A-7CB6E0D40F8D</gtr:id><gtr:outcomeId>544929ab894fa5.23380862</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Research Network (Welsh Government - Ser Cymru)</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Government of Wales</gtr:fundingOrg><gtr:id>B7CDD8E2-A1B0-471C-9493-8B260EAF9328</gtr:id><gtr:outcomeId>53cd289214e059.72674107</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Mitochondrial toxicity pathways</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>United Kingdom Environmental Mutagen Society (UKEMS)</gtr:fundingOrg><gtr:id>EFFB3EA2-FB22-417E-83C9-675D3DCF94C8</gtr:id><gtr:outcomeId>56dd9daa5b0559.33517343</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Validating commercial (Mattek) primary skin models for studying DNA damage and mutation. Coupling skin models to automation in chromosome damage analysis</gtr:description><gtr:id>0BDC3E74-2CBD-44FF-BF79-CEC3B3A13499</gtr:id><gtr:impact>Helped validate the 3D skin model as an animal replacement for cosmetics in particular. Worked with Proctor and Gamble to validate the automated analysis of topically applied chemical induced chromosome damage</gtr:impact><gtr:outcomeId>53cd2c8a97f687.98960873</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Skin models to study DNA damage induction</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7EDF3164-AE91-4ECD-82F6-F766F044C4A1</gtr:id><gtr:title>p53 may be important for avoidanace of false positives in genotoxicity testing</gtr:title><gtr:parentPublicationTitle>European Environmental Mutagen Society (EEMS), Lancaster UK, July 2014</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbe056c0ceabcf854a38d1b542d92f70"><gtr:id>cbe056c0ceabcf854a38d1b542d92f70</gtr:id><gtr:otherNames>Chapman KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>544921424cbb06.76367597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EC912EF-AEBE-4BE4-A4D1-7DB2AA9012D1</gtr:id><gtr:title>Automation and validation of micronucleus detection in the 3D EpiDerm? human reconstructed skin assay and correlation with 2D dose responses.</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbe056c0ceabcf854a38d1b542d92f70"><gtr:id>cbe056c0ceabcf854a38d1b542d92f70</gtr:id><gtr:otherNames>Chapman KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>doi_14053_age_geu011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C5F62F7-AF6E-44C2-BD91-17CC7CB4D9CD</gtr:id><gtr:title>A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32d0bc3e81cae4c9ba7175c3292dfe74"><gtr:id>32d0bc3e81cae4c9ba7175c3292dfe74</gtr:id><gtr:otherNames>Shah UK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>5a9d53152da1e3.47788739</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F687AF1F-194F-4140-A976-88D50D01C1A8</gtr:id><gtr:title>Acute dosing and p53-deficiency promote cellular sensitivity to DNA methylating agents.</gtr:title><gtr:parentPublicationTitle>Toxicological sciences : an official journal of the Society of Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbe056c0ceabcf854a38d1b542d92f70"><gtr:id>cbe056c0ceabcf854a38d1b542d92f70</gtr:id><gtr:otherNames>Chapman KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1096-0929</gtr:issn><gtr:outcomeId>55fc21dee52962.65461005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14440E43-FA19-4527-8037-1B9F896C01B6</gtr:id><gtr:title>p53 may be important for avoidance of misleading positives in in vitro genotoxicity testing</gtr:title><gtr:parentPublicationTitle>Environmental Mutagenesis and Genomics Socity (EMGS), Florida, US, Sept 2014</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39ae9a977e9e6d240dc7de282cae1992"><gtr:id>39ae9a977e9e6d240dc7de282cae1992</gtr:id><gtr:otherNames> Chapman KE</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>537b00e4a7dc5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4336CB8C-A565-4E6B-AAF7-8B0E295A73F0</gtr:id><gtr:title>Genetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDerm?).</gtr:title><gtr:parentPublicationTitle>Particle and fibre toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dad235b253c352c4afcfe9516be355b0"><gtr:id>dad235b253c352c4afcfe9516be355b0</gtr:id><gtr:otherNames>Wills JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1743-8977</gtr:issn><gtr:outcomeId>58b94d363bd614.20078035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>228270C2-2E7A-43C1-80D6-081900450AF6</gtr:id><gtr:title>Recommendations, evaluation and validation of a semi-automated, fluorescent-based scoring protocol for micronucleus testing in human cells.</gtr:title><gtr:parentPublicationTitle>Mutagenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25f131e415a96e54825ecb4e4ccaa623"><gtr:id>25f131e415a96e54825ecb4e4ccaa623</gtr:id><gtr:otherNames>Seager AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0267-8357</gtr:issn><gtr:outcomeId>55ffc0667fce25.89926805</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000821</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>